The North America Wound Care Biologics Market was valued at USD 1.06 Billion in 2024 and is expected to reach USD 2.06 Billion by 2032, growing at a CAGR of 8.56% (2025-2032).
The Middle East and Africa Wound Care Biologics Market was valued at USD 247.46 Million in 2024 and is expected to reach USD 403.43 Million by 2032, growing at a CAGR of 6.3% (2025-2032).
The Europe Wound Care Biologics Market was valued at USD 491.79 Million in 2024 and is expected to reach USD 924.53 Million by 2032, growing at a CAGR of 8.21% (2025-2032).